Physician profile
Lauren E Nitz
NPI 1801219175
$929.04
in general payments reported to CMS, 2019-2025
25 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $237 · 2022: $170 · 2023: $170 · 2024: $120 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.26 | 2022-2025 | Lifevest |
| Pfizer INC. | $85.68 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $83.07 | 2021-2024 | Xarelto |
| Becton, Dickinson and Company | $74.22 | 2025 | Hemosphere, Arista |
| Amgen INC. | $68.13 | 2021-2024 | Repatha |
| Edwards Lifesciences Corporation | $64.19 | 2021-2025 | Hemosphere |
| Smith+Nephew, INC. | $57.49 | 2023 | Pico, Renasys Go V2 Home |
| Silk Road Medical, INC. | $50.05 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $43.17 | 2022-2025 | Camzyos |
| Kci USA, INC. | $30.36 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.06 | 2021-2022 | |
| Boston Scientific Corporation | $24.47 | 2021 | |
| Medtronic, INC. | $24.43 | 2025 | Penditure |
| Bridgebio Pharma, INC. | $23.12 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $20.06 | 2025 | Bridion |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $19.05 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $17.91 | 2022 | |
| Organogenesis INC. | $17.04 | 2021 | |
| Chiesi USA, INC. | $16.52 | 2022 | |
| Terumo Medical Corporation | $15.97 | 2021 | |
| Conetic Solutions, INC. | $15.73 | 2023 | |
| Cvrx, INC. | $15.45 | 2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $15.28 | 2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $14.15 | 2025 | Wainua |
| Acacia Pharma INC | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Nitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.